GM
Housey Pharmaceutical Research Laboratories Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Axulin | Not specified | Commercial |
| Diabetes Therapeutic | Diabetes | Not specified |
| Theramutein Program | Drug-resistant cancers | Pre-clinical/Discovery |
Leadership Team at Housey Pharmaceutical Research Laboratories
TK
Thomas Klema, CPA, MBA
Chief Financial Officer
EB
Ed Bastyr, III, M.D.
Chief Medical Officer
TR
Timothy R. Franson, M.D.
Head of Global Regulatory Affairs